FILTER
FILTERED INTERVIEW RESULTS
Trevor Martin
CO-FOUNDER & CEO, MAMMOTH BIOSCIENCES
"Ultimately, we aim to fine-tune this foundational technology that can be applied to innumerable challenges across a variety of industries, making biology become more like software and programming."
Alan Petro
CEO, NEW VISION PHARMACEUTICALS
"We had a client approach us to work on a rapid Covid test, wanting to produce a single-use vial for at-home testing. It was only six weeks between when we had our initial discussion to when we had produced the product for them."
Lars Schneider
PRESIDENT OF BRENNTAG SPECIALTIES, AMERICAS– BRENNTAG NORTH AMERICA, INC
"Project Brenntag and our supply chain capabilities have certainly supported us, providing a clear focus between our different businesses and specializations to grow in the pharma and life science markets."
Donna LaVoie
PRESIDENT & CEO, LAVOIEHEALTHSCIENCE
"The surge of communication need has increased exponentially as companies recognize the necessity of conveying a differentiated story amid the unprecedented number of financings and IPOs over the last two years."
Lori Hu
MANAGING DIRECTOR, VERTEX VENTURES HC
"The M&A market has been relatively slow over the past year as pharma executives wait on the sidelines for the valuation correction to play out, but I believe that we will see M&A activities increase in this coming year."
James Sapirstein
CHAIRMAN, PRESIDENT AND CEO, FIRST WAVE BIOPHARMA
"I believe that in the near future we will be able to effectively control the Covid virus with therapeutics."
Arda Ural
PARTNER & EY AMERICAS INDUSTRY MARKETS LEADER, HEALTH SCIENCES AND WELLNESS
"Our primary objective is to pivot to areas that our clients are focusing on, such as digitalization, ESG and supply chain management."
Jay Shukla
PRESIDENT AND CEO, NIVAGEN PHARMACEUTICALS, INC.
"Nivagen has excellent connections and market access, and we are always looking to in-license FDA-approved products that leverage our expertise in launching in the US market."
Kendalle O’Connell
PRESIDENT AND COO, MASSBIO
"MassBio remains focused on providing the necessary support to help companies succeed so we can continue to stay the best place in the world for life sciences."
Emer Leahy
PRESIDENT & CEO, PSYCHOGENICS
"The main trait we are looking for in partners is access to interesting chemical libraries where, combining good chemistry with our platforms, we can identify novel treatments for neuropsychiatric disorders."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Latin America Petrochemicals and Chemicals 2024 - Digital Interactive
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
